The Big View
A podcast by Reuters - Martedì
347 Episodio
-
GSK’s bid to dominate longer-life HIV drugs
Pubblicato: 05/07/2022 -
Hong Kong’s last governor on dealing with China
Pubblicato: 21/06/2022 -
Pete Stavros and his equity-for-all quest
Pubblicato: 31/05/2022 -
How Brooks ran into Warren Buffett’s arms
Pubblicato: 26/04/2022 -
Australia can charge up a war on climate change
Pubblicato: 12/04/2022 -
The cost of corporate kowtowing to China
Pubblicato: 05/04/2022 -
Why U.S.-China financial tension is hard to disarm
Pubblicato: 29/03/2022 -
How Mad Men are waking up to the metaverse
Pubblicato: 22/03/2022 -
The climate revolution is underhyped
Pubblicato: 15/03/2022 -
VCs are victims of their own success
Pubblicato: 08/03/2022 -
Ukraine war is tectonic shift for global finance
Pubblicato: 01/03/2022 -
The Exchange: Why economic walls don’t work
Pubblicato: 22/02/2022 -
The Exchange: Consumers have the retail whip hand
Pubblicato: 15/02/2022 -
The Exchange: Margrethe Vestager
Pubblicato: 08/02/2022 -
The Exchange: UniCredit’s Andrea Orcel
Pubblicato: 03/02/2022 -
The Exchange: San Francisco Fed boss Mary Daly
Pubblicato: 01/02/2022 -
The Exchange: Hydrogen wave
Pubblicato: 27/01/2022 -
The Exchange: Morgan Stanley’s James Gorman
Pubblicato: 26/01/2022 -
The Exchange: Xpeng boldly goes
Pubblicato: 18/01/2022 -
The Exchange: Zurich CEO takes on 2022’s big risks
Pubblicato: 13/01/2022
Reuters Breakingviews columnists tap their best contacts to explore the biggest issues driving business and markets today. Every Tuesday, Global Editor Peter Thal Larsen and his team tackle a pressing question with a senior executive, financier, policymaker, or other expert. The Big View helps you understand what is going on, explore all sides of the argument, and think about what happens next. [For previous The Exchange podcast users, we didn't want to leave you hanging so we've decided to repurpose this feed for the launch of The Big View podcast. You can still find the legacy episodes below marked under the old title]
